Health
Long-term effectiveness of Pfizer/BioNTech two-dose regimen mRNA vaccine – News-Medical.Net
A group of scientists from Israel sought to evaluate the long-term effectiveness of the BioNTech/Pfizer mRNA BNT162b2 vaccine….
Several studies have shown the effectiveness of the BioNTech/Pfizer messenger ribonucleic acid (mRNA) BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. Two doses of the vaccine have been shown to provide a short-term effect.
…
Continue Reading
-
Noosa News22 hours agoTammy Hembrow’s half-brother walks free after choking and stalking ex-girlfriend
-
Noosa News20 hours agoNew Story Bridge footpath decking will be similar to the South Bank boardwalk, with one footpath expected to be open by the end of 2025
-
Business23 hours agoHow to start investing in ASX shares with just $1,000
-
Business22 hours agoGuess which ASX 300 stock was downgraded to sell today